Mesoblast LtdShs Aktie

1,40EUR -0,37EUR -20,90%
Mesoblast LtdShs für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN: A0DNPW / ISIN: AU000000MSB8
<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Aktionärsstruktur

Inhaber in %
Freefloat 73,46
Silviu Itescu, PhD 6,92
M&G Investment Management Ltd. 2,41
M&G Investment Funds (3) - Recovery Fund 2,29
Thorney Investment Group Australia Pty Ltd. 1,75
Vanguard Total International Stock Index Fund 1,29
Vanguard Australian Shares Index Fund 1,14
Vanguard Developed Markets Index Fund 0,80
Vanguard Institutional Total Intl. Stock Market Index Tr. II 0,64
Independent Asset Management Pty Ltd. 0,59

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2020 2021 2022 2023 2024
Personal am Ende des Jahres 102 83 77 83 73
Umsatz pro Mitarbeiter in Mio. EUR 0,46 0,12 0,18 0,13 0,12

Bilanz (in Mio. AUD) - Aktiva

2020 2021 2022 2023 2024
Summe Umlaufvermögen 198 197 102 123 129
Summe Anlagevermögen 982 901 990 883 872
Summe Aktiva 1 180 1 099 1 091 1 006 1 002

Bilanz (in Mio. AUD) - Passiva

2020 2021 2022 2023 2024
Summe Fremdkapital 383 324 368 252 283
Summe Eigenkapital 798 774 723 754 719
Summe Passiva 1 180 1 099 1 091 1 006 1 002

Adresse

55 Collins Street, 3000 Melbourne
Telefon +61 (3) 9639-6036
Fax +61 (3) 9639-6030
Internet http://www.mesoblast.com

Management

Andrew Chaponnel
Chief Financial Officer
Dagmar Rosa-Bjorkeson
Chief Operating Officer
Eric A. Rose
Executive Director & Chief Medical Officer
Geraldine Storton
Head-Regulatory Affairs & Quality Management
Jane C. Bell
Independent Non-Executive Chairman
Jonathan Richard Symonds
Head-Corporate Finance & Strategy
Michael Schuster
Head-Pharma Partnering
Niva Sivakumar
Secretary
Paul Hughes
Head-Investor Relations Contact
Paul Simmons
Head-Research & New Product Development
Peter T. Howard
General Counsel & Corporate Executive
Philip James Facchina
Independent Non-Executive Director
Philip R. Krause
Independent Non-Executive Director
Silviu Itescu
Chief Executive Officer, Executive Director & MD
William Matt Burns
Independent Non-Executive Vice Chairman